Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
Article in The Lancet Oncology (April 2024)
The most recent citing publications are shown below. View all 229 publications that cite this research output on Dimensions.
Article in The Lancet Oncology (April 2024)
Article in Current Treatment Options in Oncology (March 2024)
Article in American Journal of Respiratory and Critical Care Medicine (March 2024)